Living Well: Sorting Out the Approach to Relapse (https://www.myeloma.org/videos/living-well-sorting-out-approach-relapse)

Double-click on the image above to view a replay of the teleconference.

In this “Living Well with Myeloma” Teleconference, IMF Chairman of the Board Dr. Brian G.M. Durie will discuss:

  • what treatments you should consider if your myeloma has relapsed, with a focus on the latest FDA-approved drugs.
  • how to individualize treatment based on a patient’s prior therapies, the length of the onset of relapse, FiSH genetic-risk status, age, and frailty score.
  • the latest clinical trials, in particular, immune therapies.

DOWNLOAD SLIDES (https://s3.us-west-1.wasabisys.com/imf-d8-prod/2020-01/Living%20Well%20Teleconference_Oct.10.2019.pdf)

 

We thank our sponsors for supporting this educational program: 
Celgene, and Takeda Oncology

Author
Dr. Brian GM Durie (https://www.myeloma.org/Brian-Durie-md)
Square Image Media
lwm19_relapse_SQ.jpg
Video
Series
Living Well with Myeloma (https://www.myeloma.org/taxonomy/term/24)
Old Id
2400
Myeloma Stage
Early Relapse (1–3 Lines of Therapy)  (https://www.myeloma.org/taxonomy/term/1496)
Late Relapse (4–6 Lines of Therapy)  (https://www.myeloma.org/taxonomy/term/1497)
Types of Therapy
Immunotherapies (CAR T; BiTE, etc.) (https://www.myeloma.org/taxonomy/term/1499)
Topics
Clinical Trials (https://www.myeloma.org/taxonomy/term/1474)
Recorded Webinars (https://www.myeloma.org/taxonomy/term/1487)
Relapse/Refractory Myeloma (https://www.myeloma.org/taxonomy/term/1488)
Source URL: https://www.myeloma.org/videos/living-well-sorting-out-approach-relapse